Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE<sup>-/-</sup> mice

Chuanrui Ma, Ronglin Xia, Shu Yang, Lipei Liu, Jing Zhang, Ke Feng, Yuna Shang, Jingtian Qu, Lingwei Li, Ning Chen,

Theranostics · 2019 · 132 citations · 49 references

DOIFull text

Open access

Concepts

Abstract

: Our study demonstrate that formononetin can substantially attenuate the development of atherosclerosis via regulation of interplay between KLF4 and SRA, which suggests the formononetin might be a novel therapeutic approach for inhibition of atherosclerosis.

References

49